TGS Files 2025 Annual Report, Reinforcing Existing Thesis Without New Catalysts

What happened

TGS filed its 2025 Annual Report on Form 20-F with the SEC on April 22, 2026, a routine procedural update that was already anticipated. This filing encapsulates the financial and operational data for the year ended December 31, 2025, which the DeepValue report has extensively analyzed, highlighting TGS's strategic pivot to liquids and midstream. The press release contains no new disclosures or material surprises, merely confirming previously reported figures and regulatory developments. Investors should note that the report underscores ongoing challenges, such as real margin compression in regulated transport despite nominal tariff increases, while liquids and midstream segments show strength. Consequently, this event does not alter the fundamental investment narrative or introduce fresh risks or opportunities.

Implication

The filing reaffirms the 2025 financials, which show robust liquids and midstream growth but persistent real EBITDA erosion in regulated transport, validating the DeepValue report's cautious stance. No new information emerges, so investors must remain focused on existing catalysts, such as the sustainability of monthly CPI/IPIM tariff adjustments and the Perito Moreno project's progress. With TGS trading at ~20x trailing earnings, the stock already prices in much of the positive news, leaving limited margin for error if policy or execution falters. Key near-term checkpoints include ENARGAS's continued tariff resolutions and Q1-26 results to assess real EBITDA trends. Therefore, maintaining a 'WAIT' rating is justified until either a pullback to ~$24 or clear evidence that regulated margins stabilize.

Thesis delta

The thesis remains unchanged; this filing does not shift the investment call. Investors should still await either a more attractive entry price or confirmation that real transport EBITDA stops declining, as the risks and opportunities are already priced in.